Embiox ApS: Financial statements 2025
CVR: 42521310
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
Embiox ApS (CVR 42521310) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 568,503 and a net result of DKK 73,331 compared with DKK 54,539 the year before. That is a decrease of 27% compared with the year before. Equity in the 2025 report amounted to DKK 120,168. The solvency ratio was 48.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 568,503
- Profit/Loss
- DKK 73,331
- Equity
- DKK 120,168
- Total Assets
- DKK 248,588
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 569 t. | 73 t. | 120 t. | 1 |
| 2024 | - | 779 t. | 55 t. | 97 t. | 1 |
| 2023 | - | 811 t. | 91 t. | 132 t. | 1 |
How creditworthy is Embiox ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Embiox ApS
Embiox ApS is a Danish company of the type Anpartsselskab based in Støvring, founded in 2021. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Daniel Mandrup. The company is owned by DMandrup Holding ApS. In 2025, the company reported a gross profit of DKK 568,503 and a net result of DKK 73,331 compared with DKK 54,539 the year before. Equity in the 2025 report amounted to DKK 120,168.